Tag: capital

NEW YORK and VIENNA, July 18, 2025 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”), a clinical-stage biopharmaceutical company developing next-generation immunotherapeutics for the treatment of cancer and serious infectious diseases, today announced its intention to voluntarily delist from the Nasdaq Capital Market (“Nasdaq”) and to deregister its common stock under Section 12(b) and Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and suspend its reporting obligations under Section 15(d) of the Exchange Act.

WARREN, N.J., July 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) announced today that the International Bureau of the World Intellectual Property Organization (WIPO) has published its international patent application (Publication No. WO 2025/129197) titled, "Systems and Methods for Predicting Immunologically Active Peptides with Machine Learning Models."

VALLOUREC
French limited liability company (société anonyme) with a Board of Directors
with share capital of € 4,767,162.72
Registered office: 12, rue de la Verrerie – 92190 Meudon, France
Registered on the Nanterre Trade and Companies Register under n° 552 142 200

VALLOUREC
Société anonyme à Conseil d’Administration
au capital de 4 767 162,72 €
Siège social : 12, rue de la Verrerie – 92190 Meudon
552 142 200 RCS Nanterre

CHARLOTTE, N.C. and STAMFORD, Conn., July 18, 2025 (GLOBE NEWSWIRE) -- HCM II Acquisition Corp., (Nasdaq: HOND), (“HCM II”), a special-purpose acquisition company and Terrestrial Energy Inc., (“Terrestrial Energy”), a developer of small modular nuclear plants using advanced reactor technology, today announced the filing of the draft registration statement on Form S-4 with the U.S. Securities and Exchange Commission (“SEC”).

18 July 2025 - Reference is made to the stock exchange announcement published by Prosafe SE ("Prosafe" or the "Company") on 24 April 2025 where it was announced that Prosafe had agreed the terms of a recapitalization (the "Recapitalization") which, inter alia, includes a recapitalization of USD 193 million into 321,635,718 new shares in the Company (the "New Shares") and an offering of up to 17,868,651 warrants to shareholders in the Company as of 16 May 2025 as registered in the Euronext Securities Oslo (VPS) on the record date 20 May 2025 (the "Warrants"), subject to final approval being obtained by all lenders.